Hardcastle, Sharni Lee, Brenu, Ekua Weba, Johnston, Samantha et al. · Health care for women international · 2016 · DOI
ME/CFS affects people very differently—some have mild symptoms while others are severely disabled. This study reviewed different tools doctors can use to measure how severe a patient's ME/CFS is based on their symptoms and ability to function physically and mentally. Using these measurement tools helps doctors and researchers identify different groups of ME/CFS patients, which could lead to better diagnosis and treatment.
ME/CFS patients often experience widely varying symptoms and disability levels, yet healthcare providers frequently lack standardized tools to measure severity. This review is important because establishing reliable severity scales could help patients receive more accurate diagnoses, enable better clinical management, and allow researchers to recruit more comparable patient groups for studies, potentially accelerating treatment discovery.
This review does not provide new empirical evidence proving that any particular severity scale is superior to others. It does not establish that using these scales will improve patient outcomes, nor does it present original data on which scales work best in real-world primary care settings. The study's conclusions about utility remain recommendations rather than validated evidence.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.